geranylgeranylacetone has been researched along with Parkinson-Disease* in 1 studies
1 other study(ies) available for geranylgeranylacetone and Parkinson-Disease
| Article | Year |
|---|---|
Pretreatment of glial cell-derived neurotrophic factor and geranylgeranylacetone ameliorates brain injury in Parkinson's disease by its anti-apoptotic and anti-oxidative property.
The aim of the present study was to determine the combined effects of glial cell-derived neurotrophic factor (GDNF) and geranylgeranylacetone (GGA) on neuron apoptosis and oxidative stress in Parkinson's disease (PD). A mouse MPTP model of PD and cellular models of H Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Injuries; Disease Models, Animal; Diterpenes; Glial Cell Line-Derived Neurotrophic Factor; Male; Mice; Mice, Inbred C57BL; Neuroglia; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; PC12 Cells; Rats | 2018 |